Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy.

Cell Death & Disease
Yu FuXuefeng Hu

Abstract

Mesenchymal stem cell transplantation (MSCT) has been recognized as a potent and promising approach to achieve immunomodulation and tissue regeneration, but the mechanisms of how MSCs exert therapeutic effects remain to be elucidated. Increasing evidence suggests that transplanted MSCs only briefly remain viable in recipients, after which they undergo apoptosis in the host circulation or in engrafted tissues. Intriguingly, apoptosis of infused MSCs has been revealed to be indispensable for their therapeutic efficacy, while recipient cells can also develop apoptosis as a beneficial response in restoring systemic and local tissue homeostasis. It is notable that apoptotic cells produce apoptotic extracellular vesicles (apoEVs), traditionally known as apoptotic bodies (apoBDs), which possess characterized miRnomes and proteomes that contribute to their specialized function and to intercellular communication. Importantly, it has been demonstrated that the impact of apoEVs is long-lasting in health and disease contexts, and they critically mediate the efficacy of MSCT. In this review, we summarize the emerging understanding of apoptosis in mediating MSCT, highlighting the potential of apoEVs as cell-free therapeutics.

References

Mar 21, 1998·The Journal of Clinical Investigation·Y IimuroD A Brenner
Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·S GronthosS Shi
Jun 27, 2002·Proceedings of the National Academy of Sciences of the United States of America·Edwin M HorwitzTed Hofmann
Apr 4, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Songtao Shi, Stan Gronthos
Apr 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Masako MiuraSongtao Shi
Oct 21, 2004·Blood·Sudeepta Aggarwal, Mark F Pittenger
Jan 29, 2005·Experimental Hematology·Nathalie BoiretMarc Gabriel Berger
Apr 4, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Massimiliano GnecchiVictor J Dzau
Jan 24, 2007·Stem Cell Reviews·Mark L Weiss, Deryl L Troyer
Aug 1, 2007·Blood·Alma J Nauta, Willem E Fibbe
Dec 13, 2007·Nature Reviews. Molecular Cell Biology·Rebecca C TaylorSeamus J Martin
May 13, 2008·Lancet·Katarina Le BlancUNKNOWN Developmental Committee of the European Group for Blood and Marrow Transplantation
Sep 13, 2008·Cell Stem Cell·Mihaela CrisanBruno Péault
Nov 20, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Qunzhou ZhangAnh D Le
Dec 10, 2009·Science Signaling·Alma ZerneckeChristian Weber
Mar 10, 2010·Cell·Shigekazu NagataKohki Kawane
Apr 7, 2010·Proceedings of the National Academy of Sciences of the United States of America·Roselynn Rodriguez-ManzanetVijay K Kuchroo
May 28, 2010·Stem Cell Research & Therapy·Takayoshi YamazaSongtao Shi
Apr 6, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jifan FengPaul T Sharpe
Nov 15, 2011·Cell·Yaron Fuchs, Hermann Steller
Dec 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Yaël Berda-HaddadGilles Kaplanski
Jan 11, 2012·Cell Research·Annita Achilleos, Paul A Trainor
Nov 20, 2012·The Journal of Clinical Investigation·Davor FrletaNina Bhardwaj

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis